Your shopping cart is currently empty

Biotin-PEG7-Maleimide is a biotinylated biochemical assay reagent, which can be used as a thiol-specific probe. Cysteine-linked ADCs prepared with N-aryl maleimides exhibit less than 20% deconjugation in thiol-containing buffer Cysteine-linked ADCs prepared with N-aryl maleimides therefore markedly enhanced stability when compared with analogous ADCs prepared using N-alkyl maleimides, which undergo 35–67% deconjugation under identical conditions. Cysteine-linked ADCs prepared with N-aryl maleimides and incorporating the anticancer drug N-phenyl maleimide monomethyl-auristatin-E (MMAE) maintain strong cytotoxicity following prolonged serum exposure, whereas N-alkyl maleimide MMAE ADCs progressively lose potency.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | - | In Stock | |
| 5 mg | $73 | - | In Stock | |
| 10 mg | $119 | - | In Stock | |
| 25 mg | $196 | - | In Stock | |
| 50 mg | $298 | - | In Stock | |
| 100 mg | $445 | - | In Stock |
| Description | Biotin-PEG7-Maleimide is a biotinylated biochemical assay reagent, which can be used as a thiol-specific probe. Cysteine-linked ADCs prepared with N-aryl maleimides exhibit less than 20% deconjugation in thiol-containing buffer Cysteine-linked ADCs prepared with N-aryl maleimides therefore markedly enhanced stability when compared with analogous ADCs prepared using N-alkyl maleimides, which undergo 35–67% deconjugation under identical conditions. Cysteine-linked ADCs prepared with N-aryl maleimides and incorporating the anticancer drug N-phenyl maleimide monomethyl-auristatin-E (MMAE) maintain strong cytotoxicity following prolonged serum exposure, whereas N-alkyl maleimide MMAE ADCs progressively lose potency. |
| Molecular Weight | 745.88 |
| Formula | C33H55N5O12S |
| Cas No. | 1898221-65-2 |
| Smiles | C(CCCC(NCCOCCOCCOCCOCCOCCOCCOCCNC(CCN1C(=O)C=CC1=O)=O)=O)[C@H]2[C@@]3([C@](CS2)(NC(=O)N3)[H])[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (107.26 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.